Klaus K. Witte

15.0k total citations · 2 hit papers
316 papers, 9.3k citations indexed

About

Klaus K. Witte is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Surgery. According to data from OpenAlex, Klaus K. Witte has authored 316 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 218 papers in Cardiology and Cardiovascular Medicine, 45 papers in Physiology and 36 papers in Surgery. Recurrent topics in Klaus K. Witte's work include Heart Failure Treatment and Management (79 papers), Cardiac pacing and defibrillation studies (71 papers) and Cardiovascular Function and Risk Factors (67 papers). Klaus K. Witte is often cited by papers focused on Heart Failure Treatment and Management (79 papers), Cardiac pacing and defibrillation studies (71 papers) and Cardiovascular Function and Risk Factors (67 papers). Klaus K. Witte collaborates with scholars based in United Kingdom, Germany and United States. Klaus K. Witte's co-authors include Andrew L. Clark, John G.F. Cleland, Björn Lemmer, Nikolay P. Nikitin, Franz Schaefer, Elke Wühl, Marianne Soergel, Otto Mehls, Ulrich Förstermann and Thomas Wallerath and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Nature Medicine.

In The Last Decade

Klaus K. Witte

302 papers receiving 9.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions

2002 576 citations Klaus K. Witte et al. profile →
Resveratrol, a Polyphenolic Phytoalexin Present in Red Wine, Enhances Expression and Activity of Endothelial Nitric Oxide Synthase

2002 538 citations Klaus K. Witte et al. profile →

Peers

Countries citing papers authored by Klaus K. Witte

Since Specialization

Citations

This map shows the geographic impact of Klaus K. Witte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus K. Witte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus K. Witte more than expected).

Fields of papers citing papers by Klaus K. Witte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus K. Witte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus K. Witte. The network helps show where Klaus K. Witte may publish in the future.

Co-authorship network of co-authors of Klaus K. Witte

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus K. Witte. A scholar is included among the top collaborators of Klaus K. Witte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus K. Witte. Klaus K. Witte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comorbidity Trajectories Before and After the Diagnosis of Heart Failure: A UK Biobank Cohort Study 2025 ·European Journal of Heart Failure ·(unknown), (unknown), Michael Drozd, Andrew MN Walker, Marilena Giannoudi, Sam Straw, Maria F. Paton, John Gierula, (unknown), Kathryn J Griffin, Klaus K. Witte, Mark T. Kearney, Richard M. Cubbon	1
2	Palliative Versorgung und Therapiezieländerung bei Herzinsuffizienz im ambulanten Bereich 2025 ·Herz ·(unknown), Mark Weber-Krüger, Hashim Abdul‐Khaliq, Bernd Alt‐Epping, (unknown), (unknown), Gerald Neitzke, Harald Rittger, (unknown), Dorit Knappe, Klaus K. Witte, Jochen Dutzmann, Franz Goss	0
3	Diabetes mellitus does not alter mortality or hospitalisation risk in patients with newly diagnosed heart failure with preserved ejection fraction: Time to rethink pathophysiological models of disease progression 2024 ·Diabetes and Vascular Disease Research ·John Gierula, Sam Straw, (unknown), Judith E. Lowry, Maria F. Paton, (unknown), Klaus K. Witte, Peter J. Grant, Stephen B. Wheatcroft, Michael Drozd, Thomas A Slater, Richard M. Cubbon, Mark T. Kearney	1
4	Echocardiographic screening for heart failure and optimization of the care pathway for individuals with pacemakers: a randomized controlled trial 2024 ·Nature Medicine ·Maria F. Paton, John Gierula, Haqeel Jamil, (unknown), Judith E. Lowry, (unknown), Thomas A Slater, (unknown), Richard Gillott, (unknown), (unknown), Richard M. Cubbon, Deborah Stocken, Mark T. Kearney, Klaus K. Witte	1
5	Efficacy and Safety of Low-Dose Protamine in Reducing Bleeding Complications during TAVI: A Propensity-Matched Comparison 2023 ·Journal of Clinical Medicine ·(unknown), (unknown), Felix Vogt, Klaus K. Witte, Nikolaus Marx, Michael Lehrke, Mohammad Almalla, Jörg Schröder	1
6	Systemic Inflammation Is Associated With Future Risk of Fatal Infection: An Observational Cohort Study 2022 ·The Journal of Infectious Diseases ·Michael Drozd, Mar Pujades‐Rodríguez, Ann W Morgan, Patrick Lillie, Klaus K. Witte, Mark T. Kearney, Richard M. Cubbon	8
7	Diabetes mellitus and the causes of hospitalisation in people with heart failure 2022 ·Diabetes and Vascular Disease Research ·(unknown), (unknown), Michael Drozd, Victoria Palin, Marilena Giannoudi, Sam Straw, Nicholas Jex, Andrew MN Walker, John Gierula, Maria F. Paton, Klaus K. Witte, Mark T. Kearney, Eylem Levelt, Richard M. Cubbon	5
8	Detrimental Immediate- and Medium-Term Clinical Effects of Right Ventricular Pacing in Patients With Myocardial Fibrosis 2021 ·Circulation Cardiovascular Imaging ·Christopher Saunderson, Maria F. Paton, Louise Brown, John Gierula, Pei G. Chew, Arka Das, Anshuman Sengupta, (unknown), Amrit Chowdhary, Aaron Koshy, (unknown), Eylem Levelt, Erica Dall’Armellina, Pankaj Garg, Klaus K. Witte, John P. Greenwood, Sven Plein, Peter Swoboda	6
9	Sexual dimorphism in adipose tissue mitochondrial function and metabolic flexibility in obesity 2021 ·International Journal of Obesity ·Amanda D. V. MacCannell, T. Simon Futers, Anna Whitehead, Amy L. Moran, Klaus K. Witte, Lee D. Roberts	23
10	Association of heart failure and its comorbidities with loss of life expectancy 2020 ·Heart ·Michael Drozd, Samuel D. Relton, Andrew MN Walker, Thomas A Slater, John Gierula, Maria F. Paton, Judith E. Lowry, Sam Straw, Aaron Koshy, (unknown), (unknown), (unknown), Robert J. Sapsford, Klaus K. Witte, Mark T. Kearney, Richard M. Cubbon	36
11	Unique Transcriptome Signature Distinguishes Patients With Heart Failure With Myopathy 2020 ·Journal of the American Heart Association ·(unknown), Sam Straw, (unknown), (unknown), Jason L. Scragg, Jessica Smith, Aaron Koshy, Eylem Levelt, Piruthivi Sukumar, John Gierula, David J. Beech, Mark T. Kearney, Richard M. Cubbon, Stephen B. Wheatcroft, Klaus K. Witte, Lee D. Roberts, T. Scott Bowen	9
12	Long-term Outcomes Are Poor in Intravenous Drug Users Following Infective Endocarditis, Even After Surgery 2019 ·Clinical Infectious Diseases ·Sam Straw, (unknown), Richard Gillott, Jianhua Wu, Klaus K. Witte, David O’Regan, Jonathan Sandoe	69
13	Diabetes Mellitus, Microalbuminuria, and Subclinical Cardiac Disease: Identification and Monitoring of Individuals at Risk of Heart Failure 2017 ·Journal of the American Heart Association ·Peter Swoboda, Adam K McDiarmid, Bara Erhayiem, David P Ripley, Laura E Dobson, Pankaj Garg, Tarique A Musa, Klaus K. Witte, Mark T. Kearney, Julian H. Barth, Ramzi Ajjan, John P. Greenwood, Sven Plein	70
14	Redefining the role of biomarkers in heart failure trials: expert consensus document 2017 ·Heart Failure Reviews ·Frank Kramer, Hani N. Sabbah, (unknown), Faı̈ez Zannad, J. Peter van Tintelen, Erik B. Schelbert, Raymond J. Kim, Hendrik Milting, Richardus Vonk, (unknown), Richard L. Clark, Klaus K. Witte, Wilfried Dinh, Burkert Pieske, Javed Butler, Mihai Gheorghiade	16
15	Rationale and Study Design of the REM-HF Study: Remote Management of Heart Failure Using Implanted Devices and Formalized Follow-Up Procedures 2014 ·European Journal of Heart Failure ·John M. Morgan, Borislav D. Dimitrov, Jas Gill, (unknown), G. André Ng, Janet M. McComb, James Raftery, Paul Roderick, Alison Seed, Simon G. Williams, Klaus K. Witte, David J. Wright, Guiqing Yao, Martín Cowie	25
16	Non-invasive Vagus Nerve Stimulation in Healthy Humans Reduces Sympathetic Nerve Activity 2014 ·Brain stimulation ·Jennifer A. Clancy, David Mary, Klaus K. Witte, John P. Greenwood, Susan A. Deuchars, Jim Deuchars	354
17	The European Cardiac Resynchronization Therapy Survey: Comparison of Outcomes between De Novo Cardiac Resynchronization Therapy Implantations and Upgrades 2011 ·European Journal of Heart Failure ·Nigussie Bogale, Klaus K. Witte, Silvia G. Priori, John G.F. Cleland, Angelo Auricchio, Fredrik Gadler, Anselm K. Gitt, Tobias Limbourg, Cecilia Linde, Kenneth Dickstein	79
18	A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure 2010 ·Health Technology Assessment ·Claire McKenna, Jane Burch, S Suekarran, Simon Walker, Ameet Bakhai, Klaus K. Witte, Melissa Harden, Kath Wright, Nerys Woolacott, Paula Lorgelly, (unknown), Stephen Palmer	41
19	Effects of Applying a Standardised Management Algorithm for Moderate to Severe Renal Dysfunction in Patients with Chronic Stable Heart Failure 2006 ·European Journal of Heart Failure ·Ramesh de Silva, Nikolay P. Nikitin, Klaus K. Witte, Alan S. Rigby, Huan Loh, Anthony A. Nicholson, Sunil Bhandari, Andrew L. Clark, John G.F. Cleland	17
20	Clinical Trials Update: Highlights of the Scientific Sessions of the American Heart Association Year 2000: Val HeFT, COPERNICUS, MERIT, CIBIS-II, BEST, AMIOVIRT, V-MAC, BREATHE, HEAT, MIRACL, FLORIDA, VIVA and the First Human Cardiac Skeletal Muscle Myoblast Transfer for Heart Failure 2001 ·European Journal of Heart Failure ·Simon Thackray, Klaus K. Witte, Aleem Khand, (unknown), Andrew L. Clark, John G.F. Cleland	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact